AOD 9604: Chemical Identity AOD 9604 is a synthetic growth hormonederived peptide fragment corresponding to the C-terminal lipolytic region of human GH, with an additional N-terminal tyrosine residue incorporated to improve structural stability in laboratory systems
COA / Lab results Evidence: Preclinical Pros Studied for tendon, ligament, muscle and bone repair Angiogenic and gut-protective action in animal models Stable in gastric juice, unlike many growth-factor peptides Commonly paired with TB-500 in recovery protocols Cons Evidence is preclinical animal/in-vitro only, no human trials Human efficacy and dosing unestablished Pros and cons summarise available published data from peer-reviewed studies
This market-leading thermogenic fat burner has millions of satisfied customers, tens of thousands of verified reviews, and a clinical study supporting its efficacy
Jardiance European Public Assessment Report
Preclinical studies have suggested that these medications may support bone formation, whereas clinical findings have been largely neutral, underscoring the ongoing uncertainty about their net skeletal effects
PMID: 17403099 30
